Outcomes and survival of tracheostomised patients during the COVID-19 pandemic in a third level hospital.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 17 06 2021
accepted: 16 07 2021
pubmed: 13 10 2021
medline: 10 5 2022
entrez: 12 10 2021
Statut: ppublish

Résumé

Analyse the evolution and outcomes of COVID-19 tracheostomised patients. Clarify if this cohort presents an increased risk of haemorrhagic complications and verify the correlation between some risk factors with increased mortality. A retrospective single-centre observational study of a prospective cohort of all COVID-19 patients admitted to our centre between March and April 2020. A control group was obtained from a historical cohort of patients who required tracheostomy due to prolonged invasive mechanical ventilation (IMV) before 2020. A total of 1768 patients were included: 67 tracheostomised non-COVID-19 patients (historic cohort), 1371 COVID-19 patients that did not require ICU admission, 266 non-tracheostomised COVID-19 patients and 64 tracheostomised COVID-19 patients. Comparing the obesity prevalence, 54.69% of the tracheostomised COVID-19 patients were obese and 10.53% of the non-tracheostomised COVID-19 patients (p < 0.001). The median of ICU admission days was lower (p < 0.001) in the non-tracheostomised cohort (12.5 days) compared with the COVID-19 tracheostomised cohort (34 days). The incidence of haemorrhagic complications was significantly higher in tracheostomised COVID-19 patients (20.31%) compared with tracheostomised non-COVID-19 patients (5.97%) and presented a higher percentage of obesity, hypertension, diabetes and smoking, significantly different from the historic cohort (p < 0.001). A Cox model showed that tracheostomy had no statistically significant effect on mortality in COVID-19 patients. Obesity and smoking may be risk factors for tracheostomy in COVID-19 patients, tracheostomised COVID-19 patients present a higher risk of bleeding complications than those admitted for other reasons and an elevated LDH and INR on ICU admission may be associated with increased mortality.

Identifiants

pubmed: 34637016
doi: 10.1007/s00405-021-07120-w
pii: 10.1007/s00405-021-07120-w
pmc: PMC8506095
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3095-3103

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Eur Arch Otorhinolaryngol. 2021 Feb;278(2):313-321
pubmed: 32556788
Ann Surg. 2020 Sep 1;272(3):e181-e186
pubmed: 32541213
Ann Thorac Surg. 2020 Sep;110(3):1006-1011
pubmed: 32339508
Rev Clin Esp. 2020 Jun 26;:
pubmed: 32680592
Eur Arch Otorhinolaryngol. 2020 Jul;277(7):2133-2135
pubmed: 32322959
Eur Arch Otorhinolaryngol. 2021 May;278(5):1595-1604
pubmed: 32740720
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2403-2404
pubmed: 32458121
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
Obes Res Clin Pract. 2020 Jul - Aug;14(4):295-300
pubmed: 32660813
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2173-2184
pubmed: 32314050
Eur Arch Otorhinolaryngol. 2021 Mar;278(3):781-789
pubmed: 32656673
JAMA Otolaryngol Head Neck Surg. 2020 Oct 08;:
pubmed: 33034625
JAMA Otolaryngol Head Neck Surg. 2021 Mar 1;147(3):239-244
pubmed: 33331855
Oral Oncol. 2020 Sep;108:104844
pubmed: 32526655
Am J Otolaryngol. 2020 Jul - Aug;41(4):102535
pubmed: 32402693
Laryngoscope. 2003 Oct;113(10):1777-9
pubmed: 14520105
Lancet Respir Med. 2020 Jul;8(7):717-725
pubmed: 32422180
Laryngoscope. 2020 Nov;130(11):2546-2549
pubmed: 32368799
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Otolaryngol Head Neck Surg. 2020 Apr 27;49(1):23
pubmed: 32340627
Br J Anaesth. 2020 Dec;125(6):872-879
pubmed: 32988602
Eur Arch Otorhinolaryngol. 2021 May;278(5):1605-1612
pubmed: 32749607
Otolaryngol Head Neck Surg. 2020 Jul;163(1):170-178
pubmed: 32423368

Auteurs

Marta Mesalles-Ruiz (M)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain. mmesalles@bellvitgehospital.cat.
Departament de Ciències Clíniques, Universitat de Barcelona, Carrer de Casanova 143, 08036, Barcelona, Spain. mmesalles@bellvitgehospital.cat.

Miriam Hamdan (M)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Gabriel Huguet-Llull (G)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
Departament de Ciències Clíniques, Universitat de Barcelona, Carrer de Casanova 143, 08036, Barcelona, Spain.

Anna Penella (A)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Alejandro Portillo (A)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Eva Bagudà (E)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Marta Capelleras (M)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

José Maria Caballero (JM)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Mireia Golet (M)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Marta Fulla (M)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
Departament de Ciències Clíniques, Universitat de Barcelona, Carrer de Casanova 143, 08036, Barcelona, Spain.

Ricardo Bartel (R)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
Departament de Ciències Clíniques, Universitat de Barcelona, Carrer de Casanova 143, 08036, Barcelona, Spain.

Enric Cisa (E)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Francesc Cruellas (F)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Jordi Tornero (J)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Henry Rafael Lares (HR)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Anna Farré (A)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Javier Skufca (J)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Julio Nogués (J)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Manuel Mañós (M)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
Departament de Ciències Clíniques, Universitat de Barcelona, Carrer de Casanova 143, 08036, Barcelona, Spain.

Xavier Gonzàlez-Compta (X)

Otorhinolaryngology Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga, s/n, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.
Departament de Ciències Clíniques, Universitat de Barcelona, Carrer de Casanova 143, 08036, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH